Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Vaccines
•
Allergy & Immunology
Do mRNA vaccines lead to increased rates of acute/chronic urticaria?
Related Questions
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
How long do you counsel patients to wait after rituximab therapy before getting live vaccines?
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
Do you consider immunoglobulin replacement in a patient who has rapidly waning vaccine titers but does appropriately respond to revaccination?
Do patients with a PEG allergy have a contraindication to receiving mRNA vaccines?
Why are influenza and COVID vaccines still recommended for patients on immunoglobulin replacement therapy?
How do you manage recurrent epistaxis from nasal steroids?
Do you look for local IgE production in the nares with negative SPT and IgE testing if the clinical history suggests AR and the patient desires AIT?
How do you decide when to add a second biologic agent to a patient’s asthma treatment who has either not responded or had a partial response to dupilumab, omalizumab, mepolizumab, or tezepelumab?
Is there a role for use of dupilumab for hypereosinophilic GI disorders distal to the esophagus?
